Riskpilot← Back to searchSign inGet full accessWELLVITA ApS
APSActiveCVR 32782787Energivej 4Retail sale of pharmaceutical products · NACE 4773Est. 201028 employees
Revenue 2025
DKK 15,2M
-26% vs 2024
EBITDA margin
13.1%
-56% vs 2024
Equity ratio
29.7%
Financial strength
Net profit 2025
DKK 32K
-98% vs 2024
| Revenue | DKK 15,2M | -26% |
| EBITDA | DKK 2M | -56% |
| Net profit | DKK 32K | -98% |
| Total assets | DKK 21M | +3% |
| Equity | DKK 6,3M | -31% |
| Employees | 28 | — |
Legal name
WELLVITA ApS
CVR number
32782787
Legal form
Anpartsselskab
NACE code
4773 · Retail sale of pharmaceutical products
Founded
8. marts 2010
Share capital
DKK 80.000
Employees
28 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er handel.
Address
Energivej 4
Phone
+4575181611
Email
bogholderi@mezina.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.567 | 2.171 | 7.883 | 16.542 | 21.963 | 20.668 | 23.253 | 14.007 | 22.578 | 23.790 | 21.994 | 22.968 | 20.497 | 15.171 |
| Staff expenses | -1.751 | -2.033 | -3.502 | -6.046 | -9.402 | -10.784 | -12.039 | -13.086 | -18.094 | -17.757 | -15.170 | -15.666 | -15.988 | -13.187 |
| EBITDA | -184 | 138 | 4.381 | 10.496 | 12.561 | 9.884 | 11.214 | 921 | 4.484 | 6.033 | 6.823 | 7.303 | 4.509 | 1.985 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -29 | -120 | -584 | -1.038 | -1.445 | -1.740 | -2.016 | -2.202 |
| EBIT | -184 | 138 | 4.381 | 10.496 | 12.561 | 9.884 | 11.186 | 801 | 3.900 | 4.995 | 5.378 | 5.563 | 2.494 | -218 |
| Net financials | 115 | 26 | -804 | -377 | 2.314 | 3.960 | 5.117 | 5.256 | 599 | 371 | 740 | 38 | 183 | 196 |
| Profit before tax | -69 | 164 | 3.577 | 10.119 | 14.875 | 13.844 | 16.302 | 6.057 | 4.498 | 5.366 | 6.117 | 5.601 | 2.676 | -22 |
| Tax | -45 | 40 | 1.088 | 2.472 | 2.764 | 2.170 | 2.460 | 263 | 884 | 1.094 | 1.219 | 1.253 | 582 | -55 |
| Net profit | -24 | 124 | 2.489 | 7.647 | 12.111 | 11.674 | 13.842 | 5.793 | 3.615 | 4.272 | 4.898 | 4.348 | 2.094 | 32 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.906 | 3.942 | 6.988 | 17.003 | 28.908 | 30.654 | 38.402 | 43.646 | 48.610 | 27.291 | 26.639 | 19.883 | 20.380 | 21.022 |
| Equity | 278 | 364 | 2.844 | 10.454 | 22.540 | 23.122 | 28.139 | 19.325 | 20.128 | 14.257 | 12.875 | 11.086 | 9.088 | 6.253 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.114 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.628 | 3.578 | 4.129 | 6.148 | 6.368 | 7.532 | 10.263 | 24.255 | 28.178 | 11.630 | 13.281 | 8.235 | 10.696 | 14.180 |
| Total debt | 2.628 | 3.578 | 4.129 | 6.148 | 6.368 | 7.532 | 10.263 | 24.255 | 28.178 | 12.744 | 13.281 | 8.235 | 10.696 | 14.180 |
EBITDA margin
13.1%
This company
15.8%
Market median
-17% vs market
20122025
Equity ratio
29.7%
This company
38.2%
Market median
-22% vs market
20122025
Return on equity
0.5%
This company
18.4%
Market median
-97% vs market
20122025
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20122025
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20122025
Debt / equity
2.36×
This company
0.62×
Market median
-281% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LS Founder | Founder | 2010 | — | — |
TH Management | Management | 2010 | — | — |
JK Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
CS Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
JL Management | Management | 2020 | — | — |
TB Management | Management | 2019 | — | — |
NH Management | Management | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2010 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
T.A.P. ApS | Company | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MidCap T ApS
WELLVITA ApS Board members of WELLVITA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Sørensen | Founder | 0 companies |
| Tommy Heinrich Nielsen | Management | 0 companies |
| Jesper Kirkemoe Kjærsgaard Jørgensen | Chief Executive Officer | 0 companies |
| Claus Svane Gleerup | Chief Executive Officer | 0 companies |
| Jacob Lachmann | Management | 0 companies |
| Thomas Bjerregaard Thomsen | Management | 0 companies |
| Niels Harding Bressendorff | Management | 0 companies |
| Lars Janus Pedersen | Board of Directors | 0 companies |